Showing results (641-650 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|August 2, 2011
Targeting RNA to treat neuromuscular diseaseFrancesco Muntoni, Matthew J A WoodNature Reviews. Drug Discovery|June 2, 2011
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseasesPeter Carmeliet, Rakesh K JainNature Reviews. Drug Discovery|June 2, 2011
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsGrant R Drummond, Stavros Selemidis, Kathy K Griendling, et al.Nature Reviews. Drug Discovery|May 3, 2011
Harnessing synthetic lethal interactions in anticancer drug discoveryDenise A Chan, Amato J GiacciaNature Reviews. Drug Discovery|May 3, 2011
Priorities in Parkinson's disease researchWassilios G Meissner, Mark Frasier, Thomas Gasser, et al.Nature Reviews. Drug Discovery|November 1, 2011
Quantifying factors for the success of stratified medicineMark R Trusheim, Breon Burgess, Sean Xinghua Hu, et al.Nature Reviews. Drug Discovery|November 1, 2011
Rapamycin passes the torch: a new generation of mTOR inhibitorsDon Benjamin, Marco Colombi, Christoph Moroni, et al.Nature Reviews. Drug Discovery|December 2, 2011
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseasesDaniel W Neef, Alex M Jaeger, Dennis J ThieleNature Reviews. Drug Discovery|February 28, 2009
Molecular targets for cancer chemopreventionWilliam N William, John V Heymach, Edward S Kim, et al.Nature Reviews. Drug Discovery|January 4, 2012
The pharmacological landscape and therapeutic potential of serine hydrolasesDaniel A Bachovchin, Benjamin F CravattPageof 130